BOS 0.00% 1.5¢ biosignal limited

biotechnologynews.net : bos article, page-2

  1. 869 Posts.
    lightbulb Created with Sketch. 24
    That was an interesting article Profit Taker. A good roundup of the state of affairs. Keeps BOS on the radar too.

    Hard to judge how BOS stands against competitors. Certainly BOS looks to have the commercial links. This is important. Hard to say now if BOS has the best compounds. However, it is not always the best product that makes the money. It's the one that makes it in the market.

    Well, wait and see I guess. SP is waning.
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.